It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
"It is shocking that medical workers in Brazil will have access to HCQ as a prophylaxis while Americans are blocked by the FDA from accessing the same medication for the same use," observes AAPS Executive Director Jane Orient, M.D. "There is no legal or factual basis for the FDA to limit use of HCQ," states AAPS General Counsel Andrew Schlafly. "The FDA's restrictions on HCQ for Americans are completely indefensible in court." Many foreign nations, including China, India, South Korea, Costa Rica, United Arab Emirates, and Turkey, use HCQ for early treatment and prevention of COVID-19, AAPS points out. "Entrenched, politically biased officials at the FDA should not be allowed to interfere with Americans' right to access medication donated to the federal government for public use," Schlafly says. "By preventing Americans' use of HCQ as a prophylaxis, the FDA is infringing on First Amendment rights to attend religious services or participate in political events such as political conventions, town halls, and rallies in an important election year."
originally posted by: Waterglass
So why doesn't the White House talk about the Association of American Physicians & Surgeons lawsuit on ban of Hydroxychloroquine? Why doesn't the White House talk about SEMOS findings on Hydroxychloroquine?
originally posted by: Waterglass
So why doesn't the White House talk about the Association of American Physicians & Surgeons lawsuit on ban of Hydroxychloroquine? Why doesn't the White House talk about SEMOS findings on Hydroxychloroquine?
As the coronavirus death toll mounts, global health authorities are reminding that tuberculosis is deadliest infectious disease in the world. Over a million deaths are reported every year.
originally posted by: Waterglass
So wassup with dis:
WHO: Tuberculosis is the world’s deadliest infectious disease
Plus I am here to save er "help" you. As an older gentlemen you need to followup on your aerosols:
"By preventing Americans' use of HCQ as a prophylaxis, the FDA is infringing on First Amendment rights to attend religious services or participate in political events such as political conventions, town halls, and rallies in an important election year."
originally posted by: AugustusMasonicus
Probably because they're smart enough to not associate themselves with a group that promotes creationism.
originally posted by: incoserv
Yeah, those silly creationists. It make so much more sense to believe that the entire perfectly ordered and structured cosmos just accidently and purposelessly farted itself into existence out of the great void of nothingness.
I mean, creationists ... believing by some line of observation and reason that some higher intelligence created the incredible order and structure that is evident in this meaningless, purposeless, happenstancical jumble of perfectly order molecules and infinitely complex physical laws that hold them together! Talk about blind faith!
:
Plaintiff’s members and the entire public are being denied early access to safe, inexpensive HCQ, a medication which is conquering COVID-19 in other countries. Countries with underdeveloped health care systems are using HCQ early and attaining far lower mortality than in the United States.
FDA’s recommendations are really schizophrenic. We used HCQ in pregnant women. We used it in children. We use it without monitoring in countries for malaria prophylaxis. Defendants do not address the numerous public statements by eminent professors and others which emphasize the proven safety of hydroxychloroquine for 65 years. Defendants do not and cannot dispute any of this. Defendants fail to submit affidavits or any other evidence, thereby essentially defaulting on Plaintiff’s motion.
Defendants do not deny their own political and financial conflicts of interest which result in their wrongful interference with HCQ access.
The medical science at issue here is simple and less complex than what courts decide every day in medical malpractice cases. Indeed, if a physician failed to recommend HCQ use early for treatment of COVID-19, then a patient harmed by that lack of treatment might have a valid cause of action for malpractice which a court would decide without deference to FDA officials, none of whom are practicing medical doctors themselves.
Defendants initially limited the use of HCQ from the Stockpile to patients only after they have been hospitalized, which is unnecessarily late in the progression of the disease. Delaying use of an anti-viral until late in the disease progression obviously reduces its effectiveness.
Defendants perpetuate their interference by falsely stating and implying that HCQ should not be used at any time to treat COVID, upon which States rely in blocking access. Defendants have been devastatingly tragic to the American people and our constitutional rights.
Defendants blithely insist that this Court has no cause to interfere with decisions of public health officials and scientists responding to COVID-19. Defendants argue that this Court must defer to interference by a handful of bureaucrats in Washington, D.C., regardless of their demonstrated political bias against our President and financial conflicts-of-interest in preferring rivals to hydroxychloroquine.
Because there is no possible justification for Defendants’ conduct, they resort to procedural attempts to avert a substantive ruling. Countries such as in Western Europe having more liberal views about the sanctity of life have been more likely to block access to HCQ.
Defendants’ primary argument is to assert that Plaintiff AAPS somehow lacks standing. But amid the COVID-19 pandemic, is there anyone who lacks standing to object to interference with medication for it? It is difficult to imagine an issue for which more universal standing exists, and AAPS has both standing and a valid cause of action.
Defendants’ first argument is that AAPS and its members assert generalized grievances against FDA’s actions. The injuries here are literally life-and-death issues, as well as core constitutional rights like the freedom to practice medicine and to associate; these are not “abstract” or “intellectual”interests. FDA’s actions have caused redressable injuries to doctors and patients.
Defendants falsely pretend that they do not interfere with the distribution of HCQ, Defendants do prohibit any access by Dr. Doe and his patients to the HCQ in the Stockpile, despite the donors’ intent for it to be used in treating COVID-19 patients.
Defendants instead insist on prohibiting all access by Dr. Doe and his patients, and millions of others in similar situations, from having any access to the HCQ Stockpile. Defendants’ own improper statements in revoking their EUA reinforce how they intend to interfere with access to HCQ.
Defendants’ own opposition brief broadly credits Defendants for directing the Nation amid the coronavirus pandemic. Defendants imply near the end of their brief that they alone have “the background, competence, and expertise to assess public health,” and that the Court should defer to them on that basis. But in arguing against standing, Defendants try to downplay their significance and influence. Which is it?
Defendants also argue that AAPS cannot assert standing for patients. AAPS physician members are themselves subject to COVID-19, and thus are themselves patients. This Court has jurisdiction for “declaratory, injunctive or mandamus relief” against Defendants, notwithstanding their status as federal officers and offices.
Defendants argue that FDA’s rescission of the EUA moots this litigation. Nothing in the relevant statutes even arguably prevents judicial review of agency actions outside of EUA actions.
Defendants devote more than a third of their of their argument to insisting that Plaintiff AAPS has not stated a cause of action. Under Defendants’ reasoning, they can falsely disparage HCQ with impunity, deny access to HCQ in the Stockpile while it wastes away amid a pandemic, issue an irrational EUA and a senseless revocation, without any cause of action against it.
Defendants do not argue that there is anything implausible about AAPS’s allegations. Defendants do not dispute in any way the allegations by AAPS of their political bias against President Trump, and their conflicts of interest with respect to more expensive medications which are rivals to HCQ.
Defendants make an incorrect argument that their conduct is somehow “excepted by statute from judicial review” under the Administrative Procedure Act. Defendants resort to factual arguments about whether it committed an equal protection violation by prohibiting use of HCQ outside of hospitals.
Defendants argue that the relevant statutes commit FDA’s EUA actions to agency discretion. They are wrong under the APA, under pre-APA review, and under constitutional review.
Defendants argue repeatedly that HCQ remains commercially available. These repeated claims of commercial availability ignore the fact that FDA’s false, statutorily unauthorized, and reviewable statements – which are not backed by any data – have created a legal impediment to commercial use of HCQ.
Defendants implicitly concede that FDA’s safety-for-COVID argument makes no sense for prophylactic use of HCQ because the patient does not have COVID-19. FDA disparaged the safety and efficacy of HCQ for COVID-19 without any data.
Defendants cannot justify their arbitrary actions in interfering with access to HCQ. Defendants cannot explain why they limited use of HCQ until after hospitalization, when anti-viral medication is most effective when given soon after exposure to the virus. Instead, Defendants make a cut-and-paste type argument that they supposedly acted within their discretion
Defendants say they should never be enjoined, no matter how badly they behave. Discretionary authority in the hands of Defendants does not justify their irrational interference with access to HCQ.
Defendants are simply wrong in implying that they can do whatever they want, and even waste a stockpile of lifesaving medication, without any accountability in court.
COVID mortality correlates with the countries’ interference with public access to HCQ. Interference with HCQ access is itself correlated with countries skeptical about the sanctity of life.
originally posted by: AugustusMasonicus
originally posted by: Waterglass
So why doesn't the White House talk about the Association of American Physicians & Surgeons lawsuit on ban of Hydroxychloroquine? Why doesn't the White House talk about SEMOS findings on Hydroxychloroquine?
Probably because they're smart enough to not associate themselves with a group that promotes creationism.